The ongoing updates include the latest evidence- and expert-consensus-based best practices for managing breast, colon, non-small cell lung, and prostate cancers—four cancer types that account for more than half of the overall burden of cancer in Europe1—as well as cutaneous melanoma, which also ranks among the top 10 incident cancers in Europe2.

"Nearly half of the 1.1 million registered users of the NCCN Guidelines are from outside of the United States," said Robert W. Carlson, MD, Chief Executive Officer, NCCN. "The NCCN Guidelines are already the most frequently updated guidelines in any medical discipline, and numerous independent studies have shown that following these recommendations leads to better outcomes for patients. That means we have a responsibility to continue making these guidelines relevant and accessible worldwide. Our work with the ECO Foundation is one way we support this goal. Other NCCN Global initiatives include language translations and adaptations/harmonizations for varying resource levels."

"All the members of the ECO Foundation are proud of this collaboration with NCCN, and we strongly believe that with this initiative we have taken an important step towards advancing and maintaining the excellence of the entire cancer community," said Dr. Vicente Guillem, President of the ECO Foundation. "The agreement we reached with NCCN for the translation and adaptation of these five clinical practice guidelines into Spanish has been an exciting and pioneering project at the European level."

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at  NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.